Table 3.
ITT and per‐protocol analyses of the primary efficacy endpoint
| Total | Type of preparation | ||
|---|---|---|---|
| WD/PICO | CF/PEG + SPMC | ||
| ITT analysis | |||
| Number of patients in ITT analysis | 250 | 125 | 125 |
| Successful bowel preparation, n (%) | 149 (59.6) |
72 (57.6) |
77 (61.6) |
| Difference between groups (one‐sided 95% CI) | −4.0% (−14.2 to 6.2%) | ||
| Per‐protocol analysis | |||
| Number of patients in per‐protocol analysis | 230 | 112 | 118 |
| Successful bowel preparation, n (%) | 149 (64.8) |
72 (64.3) |
77 (65.3) |
| Difference between groups (one‐sided 95% CI) | −1.0% (−11.3 to 9.4%) | ||
CF, clear fluid; ITT, intention to treat; PEG, polyethylene glycol; PICO, picosalax; SPMC, sodium picosulfate/magnesium citrate; WD, White Diet.